Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives
Kun Peng, Bing‐Bing Liang, Wenting Liu, et al.
Coordination Chemistry Reviews (2021) Vol. 449, pp. 214210-214210
Closed Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses
Kun Peng, Yue Zheng, Wei Xia, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 8, pp. 2790-2832
Closed Access | Times Cited: 79
Recent Advances of Platinum‐Based Anticancer Complexes in Combinational Multimodal Therapy
Tianyuan Zhong, Jie Yu, Yong Pan, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 22
Open Access | Times Cited: 36
Platinum complexes with aggregation-induced emission
Shengyi Yang, Yingying Chen, Ryan T. K. Kwok, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 11, pp. 5366-5393
Open Access | Times Cited: 14
Metal N-heterocyclic carbene complexes as potential metallodrugs in antitumor therapy
Yifan Zhang, Yi-Kui Yin, Heng Zhang, et al.
Coordination Chemistry Reviews (2024) Vol. 514, pp. 215941-215941
Closed Access | Times Cited: 13
Disruption of Zinc Homeostasis by a Novel Platinum(IV)‐Terthiophene Complex for Antitumor Immunity
Xuxian Su, Bin Liu, Wenjin Wang, et al.
Angewandte Chemie International Edition (2022) Vol. 62, Iss. 8
Closed Access | Times Cited: 47
Ruthenium(II)–Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium Homeostasis
Jakub Červinka, Alberto Gobbo, Lorenzo Biancalana, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10567-10587
Open Access | Times Cited: 39
The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022
Shihao Su, Yutong Chen, Pengfei Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114680-114680
Closed Access | Times Cited: 39
Beyond mere DNA damage: Recent progress in platinum(IV) anticancer complexes containing multi-functional axial ligands
Zhiqin Deng, Guangyu Zhu
Current Opinion in Chemical Biology (2023) Vol. 74, pp. 102303-102303
Closed Access | Times Cited: 30
Recent advancements in Nanotechnology-Mediated Platinum-Based cancer therapy
Asif Mohd Itoo, Balaram Ghosh, Swati Biswas
Coordination Chemistry Reviews (2024) Vol. 508, pp. 215796-215796
Closed Access | Times Cited: 8
Synthesis, structural elucidation and anticancer activity of diorganotin(IV) complexes derived from isonicotinoyl hydrazones
S. von Ahsen, Iqra Tanvir, Noor Uddin, et al.
Inorganica Chimica Acta (2024) Vol. 564, pp. 121965-121965
Closed Access | Times Cited: 7
G-quadruplex-guided cisplatin triggers multiple pathways in targeted chemotherapy and immunotherapy
Tianzhu Ma, Liu‐Yi Liu, You‐Liang Zeng, et al.
Chemical Science (2024) Vol. 15, Iss. 25, pp. 9756-9774
Open Access | Times Cited: 7
Anticancer Diiron Aminocarbyne Complexes with Labile N-Donor Ligands
Sara Stocchetti, Ján Vančo, Giulio Bresciani, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117304-117304
Closed Access
Recent advances in ruthenium（III） complex-loaded nanomaterial for enhanced cancer therapy efficacy
Xuemei Zhong, Ye Zhang, Jian-Hua Wei
Drug Development and Industrial Pharmacy (2025), pp. 1-18
Closed Access
Enhanced Anticancer Selectivity of Cyclometalated Imidazole/Pyrazole-Imine IridiumIII Complexes Through the Switch from Cationic to Zwitterionic Forms
Zhe Liu, Kangning Lai, Pengwei Li, et al.
Inorganic Chemistry (2025)
Closed Access
Anticancer Activity Promoted by Ligand Diversity in Diiron Thiocarbyne Complexes
Ekatarina Mihajlović, Lorenzo Biancalana, Marija Mojić, et al.
European Journal of Medicinal Chemistry (2025), pp. 117364-117364
Closed Access
Engineering Supramolecular Nanomedicine for Targeted Near Infrared-triggered Mitochondrial Dysfunction to Potentiate Cisplatin for Efficient Chemophototherapy
Wei Zhang, Xiang‐Fu Du, Ben Liu, et al.
ACS Nano (2021) Vol. 16, Iss. 1, pp. 1421-1435
Closed Access | Times Cited: 48
Naphthalene Diimide-Functionalized Half-Sandwich Ru(II) Complexes as Mitochondria-Targeted Anticancer and Antimetastatic Agents
Yuliang Yang, Xiaofeng Zou, Yanyan Sun, et al.
Inorganic Chemistry (2023) Vol. 62, Iss. 24, pp. 9649-9660
Closed Access | Times Cited: 19
Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands
Pavel Štarha, Radka Křikavová
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215578-215578
Closed Access | Times Cited: 16
Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity
Sainath Babaji Aher, J. Zhu, Pundlik Rambhau Bhagat, et al.
Topics in Current Chemistry (2024) Vol. 382, Iss. 1
Closed Access | Times Cited: 5
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 5
Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance
Meng Wang, Guimei Li, Guiyang Jiang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6218-6237
Closed Access | Times Cited: 5
FETPY: a Diiron(I) Thio–Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo
Ekatarina Mihajlović, Lorenzo Biancalana, Sanja Jelača, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7553-7568
Open Access | Times Cited: 5
Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes Chelating Hybrid sp2-N/sp3-N Donor Ligands to Achieve Improved Anticancer Selectivity
Lihua Guo, Pengwei Li, Jiaxing Li, et al.
Inorganic Chemistry (2023) Vol. 62, Iss. 37, pp. 15118-15137
Closed Access | Times Cited: 13
A Golgi‐Targeted Platinum Complex Plays a Dual Role in Autophagy Regulation for Highly Efficient Cancer Therapy
Bing‐Bing Liang, Qian Liu, Bin Liu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 44
Closed Access | Times Cited: 12
Platinum-Based Mcl-1 Inhibitor Targeting Mitochondria Achieves Enhanced Antitumor Activity as a Single Agent or in Combination with ABT-199
Xing Lü, Mei‐Feng Wu, Jiang-Lun Wu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8705-8716
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top